Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Definitive Healthcare is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- SCHEDULE 13D/A2026-10-01SCHEDULE 13D/A
- 8-K2026-09-09Current report (material event)
- 8-K2026-09-02Current report (material event)
- SCHEDULE 13D2026-09-02SCHEDULE 13D
- 8-K2026-09-02Current report (material event)
- SCHEDULE 13D2026-09-02SCHEDULE 13D
- 10-Q2026-08-10Quarterly report
- 8-K2026-08-10Current report (material event)
- 8-K2026-06-24Current report (material event)
- 8-K2026-06-05Current report (material event)
- SCHEDULE 13G/A2026-05-14SCHEDULE 13G/A
- 10-Q2026-05-07Quarterly report
- 8-K2026-05-07Current report (material event)
- ARS2026-04-23Annual report to holders
- DEFA14A2026-04-23DEFA14A
- DEF 14A2026-04-23Proxy statement
- 8-K2026-04-09Current report (material event)
- 8-K2026-04-03Current report (material event)
- S-82026-02-26Employee stock plan
- 10-K2026-02-26Annual report
- 8-K2026-02-26Current report (material event)
- SCHEDULE 13G/A2026-02-09SCHEDULE 13G/A
- 10-Q2025-11-06Quarterly report
- 8-K2025-11-06Current report (material event)
- 10-Q2025-08-07Quarterly report
- 8-K2025-08-07Current report (material event)
- 8-K2025-07-23Current report (material event)
- 8-K2025-07-01Current report (material event)
- 8-K2025-06-06Current report (material event)
- SCHEDULE 13G/A2025-05-15SCHEDULE 13G/A
- SCHEDULE 13G/A2025-05-15SCHEDULE 13G/A
- SCHEDULE 13G/A2025-05-15SCHEDULE 13G/A
- SCHEDULE 13G2025-05-09SCHEDULE 13G
- 10-Q2025-05-08Quarterly report
- 8-K2025-05-08Current report (material event)
- ARS2025-04-23Annual report to holders
- DEFA14A2025-04-23DEFA14A
- DEF 14A2025-04-23Proxy statement
- S-82025-02-27Employee stock plan
- 10-K2025-02-27Annual report
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.